Late-Breaking Clinical Trial: "ADVANCE III Trial"
Maurizio Gasparini, MD reviews the Heart Rhythm 2017 Late-Breaking Clinical Trial: "Long Detection Programming In Single Chamber Defibrillators Reduces Unnecessary Therapies And Mortality: The ADVANCE III Trial".
Read more: heartrhythmjournal.com/article/S1547-5271(17)30587-8/fulltext